ITRM - Iterum Therapeutics plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 590.09M
Enterprise Value 341.81M
Trailing P/E N/A
Forward P/E 1-1.70
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)126.01
Price/Book (mrq)1.74
Enterprise Value/Revenue 358.47
Enterprise Value/EBITDA 6-0.49

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-11,863.22%

Management Effectiveness

Return on Assets (ttm)-67.42%
Return on Equity (ttm)-153.54%

Income Statement

Revenue (ttm)715k
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)-80.60%
Gross Profit (ttm)869k
EBITDA -84.68M
Net Income Avi to Common (ttm)-85.49M
Diluted EPS (ttm)-6.97
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)70.47M
Total Cash Per Share (mrq)4.9
Total Debt (mrq)21.75M
Total Debt/Equity (mrq)42.13
Current Ratio (mrq)4.36
Book Value Per Share (mrq)3.59

Cash Flow Statement

Operating Cash Flow (ttm)-79.3M
Levered Free Cash Flow (ttm)-46.73M

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-47.30%
S&P500 52-Week Change 34.92%
52 Week High 313.00
52 Week Low 34.70
50-Day Moving Average 37.75
200-Day Moving Average 36.67

Share Statistics

Avg Vol (3 month) 311.76k
Avg Vol (10 day) 34.83k
Shares Outstanding 514.37M
Float 4.52M
% Held by Insiders 18.97%
% Held by Institutions 175.71%
Shares Short (Apr 30, 2019) 452.73k
Short Ratio (Apr 30, 2019) 47.13
Short % of Float (Apr 30, 2019) 40.96%
Short % of Shares Outstanding (Apr 30, 2019) 40.37%
Shares Short (prior month Mar 29, 2019) 467.87k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A